Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • c-Myc tag Peptide: Precision Tool for Immunoassays & Canc...

    2025-10-15

    c-Myc tag Peptide: Precision Tool for Immunoassays & Cancer Biology

    Introduction: Principle and Setup of the c-Myc tag Peptide

    The c-Myc tag Peptide is a synthetic peptide mirroring the C-terminal amino acids (410-419) of human c-Myc, a pivotal transcription factor regulating cell proliferation, apoptosis, differentiation, and self-renewal. Recognized for its proto-oncogenic activity, c-Myc is central to cancer biology, making its modulation a powerful avenue for both mechanistic and translational research. The c-Myc tag peptide’s value lies in its ability to competitively inhibit anti-c-Myc antibody binding, enabling the controlled displacement of c-Myc-tagged fusion proteins from antibody complexes in immunoassays. This property is crucial for specific detection, quantification, and isolation of proteins of interest, as well as for dissecting c-Myc mediated gene amplification and signaling pathways in experimental workflows.

    The synthetic c-Myc peptide for immunoassays is highly soluble in DMSO (≥60.17 mg/mL) and water (≥15.7 mg/mL with sonication), ensuring compatibility with diverse experimental formats. Used primarily as a research reagent for cancer biology and gene regulation studies, this tool is not intended for diagnostic or clinical purposes.

    Experimental Workflows and Protocol Enhancements

    Stepwise Workflow for Displacement of c-Myc-tagged Fusion Proteins

    1. Sample Preparation: Express and purify c-Myc-tagged fusion proteins in the system of choice (e.g., mammalian cells, E. coli, or yeast). Lyse the cells under native or denaturing conditions depending on downstream applications.
    2. Antibody Binding: Incubate the lysate with anti-c-Myc antibody-conjugated agarose or magnetic beads. This step selectively captures c-Myc-tagged proteins, harnessing the specificity of the myc tag sequence.
    3. Washing: Thorough washes remove non-specifically bound proteins, ensuring high purity for downstream analysis.
    4. Elution with c-Myc tag Peptide: Prepare a solution of c-Myc tag Peptide at 1–2 mg/mL in PBS or TBS, ensuring the peptide is fully dissolved (sonication recommended for water). Add peptide to the bead-protein complex and incubate for 30–60 minutes at 4°C with gentle agitation. The synthetic peptide competitively displaces the c-Myc-tagged fusion proteins by saturating anti-c-Myc antibody binding sites.
    5. Collection and Analysis: Separate the beads magnetically or by centrifugation, collect the supernatant containing displaced protein, and analyze using SDS-PAGE, Western blot, or mass spectrometry as appropriate.

    Protocol Enhancements: For high-sensitivity applications, such as ChIP or co-immunoprecipitation, titrate the peptide concentration to optimize yield while minimizing background. Ultrasonic treatment of the peptide solution enhances solubility, particularly in aqueous buffers.

    Advanced Applications and Comparative Advantages

    Beyond Standard Immunoassays: Mechanistic and Functional Insights

    The c-Myc tag Peptide offers unique advantages over conventional elution methods (e.g., low pH, high salt, or denaturing conditions) by preserving protein conformation and function. This is critical for downstream applications such as:

    • Protein-Protein Interaction Studies: Displacement of c-Myc-tagged complexes under native conditions enables functional characterization of binding partners and transient interactomes.
    • Transcription Factor Regulation: By enabling precise control over c-Myc fusion protein recovery, the peptide facilitates quantitative studies of c-Myc-mediated gene amplification and its downstream effects on cell proliferation and apoptosis regulation. This is especially relevant in the context of proto-oncogene c-Myc in cancer research, where subtle changes in expression or activity can lead to significant phenotypic outcomes.
    • Integration with Autophagy and Immune Signaling Research: Emerging studies, such as Wu et al. (2021), highlight the interplay between transcription factors like IRF3 and selective autophagy in immune regulation. The c-Myc tag Peptide enables researchers to dissect similar regulatory circuits involving c-Myc, facilitating the study of transcription factor stability, post-translational modifications, and cellular stress responses in live-cell or in vitro systems.


    Comparatively, "c-Myc tag Peptide: Mechanistic Insights and Advanced Applications" complements this scope by providing mechanistic evidence for peptide-mediated modulation of transcription factor activity. In contrast, "c-Myc tag Peptide: Next-Gen Insights for Oncogenic Pathways" extends the discussion to autophagy and immune signaling, paralleling the reference study and underscoring the peptide’s role in unraveling complex regulatory networks. Meanwhile, "c-Myc tag Peptide: Advanced Mechanistic Insights in Cancer Biology" uniquely connects c-Myc-mediated gene amplification to autophagy mechanisms, offering a broader perspective for those exploring crosstalk between oncogenic signaling and cellular degradation pathways.

    Troubleshooting and Optimization Tips

    • Peptide Solubility: If the c-Myc tag Peptide does not dissolve readily in water, apply ultrasonic treatment as recommended. Always avoid ethanol as a solvent due to insolubility.
    • Elution Efficiency: If displacement of c-Myc-tagged fusion proteins is suboptimal, incrementally increase peptide concentration up to 5 mg/mL. Confirm the integrity and activity of anti-c-Myc antibodies, as prolonged storage or repeated freeze-thaw cycles can compromise binding capacity.
    • Specificity Controls: Use a non-specific peptide as a negative control to confirm that elution is due to competitive inhibition and not nonspecific interactions. Quantify eluted protein using densitometry or mass spectrometry for objective assessment.
    • Storage and Stability: Store lyophilized peptide desiccated at -20°C. Prepare fresh working solutions prior to each experiment; avoid long-term storage of diluted solutions, as stability may decrease.
    • Antibody Cross-Reactivity: Validate that the anti-c-Myc antibody does not cross-react with endogenous myc family proteins in your system, especially when working with mammalian lysates. This prevents confounding background signals.
    • Performance Metrics: Published reports indicate that peptide-based displacement can achieve >90% recovery of c-Myc-tagged proteins from affinity matrices under optimized conditions, while maintaining native structure and avoiding denaturation—far exceeding yields from traditional harsh elution methods (see "c-Myc tag Peptide: A Next-Generation Tool for Precision Transcription Factor Studies").

    Future Outlook: c-Myc Peptide in Advanced Cancer and Immunology Research

    As the c-Myc tag Peptide continues to empower research into transcription factor regulation, proto-oncogene amplification, and cell fate determination, its utility is poised to expand into next-generation workflows. Integration with multi-omics platforms, single-cell proteomics, and high-throughput screening will enable more precise mapping of c-Myc interactomes and downstream effectors in cancer and stem cell biology.

    The growing link between autophagy and transcription factor stability, as highlighted in Wu et al. (2021), suggests a promising avenue for leveraging the c-Myc tag Peptide in studies of cellular stress, immune evasion, and targeted therapeutic interventions. With optimized protocols and robust troubleshooting strategies, researchers can harness the full potential of this synthetic peptide to drive innovation in cancer biology and beyond.

    To explore technical datasheets, application notes, and ordering information, visit the official c-Myc tag Peptide product page.